Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Genoa Pharmaceuticals | Series A | $62.0M | San Diego, United States |
| 152 | Amra | Series Unknown | $8.9M | Linköping, Sweden |
| 153 | Macrophage Pharma | Series A | $11.0M | Englewood Cliffs, United States |
| 154 | Glionova | Series A | $5.7M | Stockholm, Sweden |
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Amra uses cloud-based, computer aided service to analytically transform MR images into body composition measurements.
Macrophage Pharma is a immune-oncology company
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
Novo Holdings has invested in 154 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Biopharma, Pharmaceutical, Medical, Health Care. The firm invests across 9 different industry categories.
Among tracked funding rounds, Genoa Pharmaceuticals received $62.0M in a Series A round. Novo Holdings's total known invested capital is $9.7B.
Novo Holdings's average investment size is $85.4M across its portfolio of 154 companies.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors